Yidu Tech surged more than 5% in early trading, achieving another breakthrough in the practice of medical artificial intelligence large models

robot
Abstract generation in progress

Yidu Tech (02158) rose more than 7% during trading; as of the time of this report, the stock was up 7.03%, trading at HK$5.48. The trading value was HK$23.4967 million.

On April 8, Yidu Tech released a voluntary announcement. The company said it won the AI-enabled healthcare initiative—an “Yin-Yi (bank-hospital) cooperation” project—for the construction of the Beijing Cancer Hospital’s artificial intelligence capabilities. The total project amount is approximately RMB 4.88M. The project is seen as another breakthrough practice by Yidu Tech in the field of medical AI large models. In the future, it will continue to deepen efforts using Beijing University Cancer Hospital as a benchmark scenario, establishing a demonstration case for the comprehensive expansion of its large-model business.

Also worth noting is that Yidu Tech recently signed a strategic cooperation agreement with the Bank of Beijing. It is understood that both sides will carry out in-depth cooperation around “smart healthcare.” Leveraging Yidu Tech’s “AI medical brain” YiduCore and its big data governance capabilities, together with the Bank of Beijing’s experience in building medical financial services and hospital scenarios, they will jointly provide smart outpatient services for hospitals, including online appointment booking, intelligent triage, real-time payment, and report lookup, as well as smart inpatient services such as admission registration, discharge settlement, and electronic invoices. The bid project also adopts the Yin-Yi cooperation model. Market expectations are that Yidu Tech will continue to deliver more projects in the bank-hospital cooperation domain going forward.

(Editor: Guo Jiandong)

     【Disclaimer】This article only represents the author’s own views and is not related to Hexun. The Hexun website makes no express or implied guarantees regarding the accuracy, reliability, or completeness of the statements, opinions, or judgments contained in the text. Please note that readers should treat this as reference only and bear all responsibility themselves. Email: news_center@staff.hexun.com
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments